12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks experienced significant movements. Jin Medical International (ZJYL) saw a substantial increase of 72.5%, while NRX Pharmaceuticals (NRXP) led the losers with a 12.1% decrease. Other notable gainers include Panbela Therapeutics (PBLA), IN8bio (INAB), Reviva Pharmaceuticals (RVPH), CNS Pharma (CNSP), and Nexalin Technology (NXL). On the losing side, bluebird bio (BLUE), Senti Biosciences (SNTI), Motus GI Holdings (MOTS), Zura Bio (ZURA), and BioAtla (BCAB) also saw declines.
December 18, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CNS Pharma's shares moved upwards by 7.51% to $1.43, with a market cap of $8.8 million.
CNS Pharma's after-market gain could indicate a positive trend, but due to its small market cap, the stock may be subject to higher volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
IN8bio's stock rose by 8.14% to $1.46, with a market cap of $63.1 million.
IN8bio's after-market increase may continue into the short term if the investor sentiment remains positive.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Nexalin Technology's stock rose 6.55% to $0.39, with a market cap of $2.9 million.
Nexalin Technology's stock increase points to potential short-term interest, though the small market cap suggests higher risk and volatility.
CONFIDENCE 65
IMPORTANCE 40
RELEVANCE 60
POSITIVE IMPACT
Panbela Therapeutics' shares increased by 18.81% to $1.2, with a market cap of $6.1 million.
The notable rise in Panbela Therapeutics' stock price could indicate positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Reviva Pharmaceuticals' stock increased by 7.58% to $3.83, with a market cap of $106.9 million.
The rise in Reviva Pharmaceuticals' shares could suggest a positive outlook, potentially leading to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Jin Medical International's stock soared by 72.5% to $175.76, with a market cap of $1.3 billion.
The significant after-market gain for Jin Medical International suggests strong investor confidence or a positive reaction to recent news, which could lead to continued short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
BioAtla's shares fell 6.3% to $1.86, with a market cap of $89.1 million.
The decrease in BioAtla's shares suggests a bearish outlook, which may result in continued short-term downward movement.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
bluebird bio's stock declined by 11.48% to $2.7, with a market cap of $295.2 million.
bluebird bio's decline in the after-market may continue in the short term if the negative sentiment persists.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Motus GI Holdings' stock declined by 7.91% to $1.98, with a market cap of $1.3 million.
Motus GI Holdings' decline may signal negative investor sentiment, which could lead to further short-term decreases in stock price.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
NRX Pharmaceuticals' shares decreased by 12.1% to $0.37, with a market cap of $31.5 million.
The significant drop in NRX Pharmaceuticals' stock price could indicate negative news or investor sentiment, likely leading to continued short-term downward pressure.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Senti Biosciences' shares decreased by 8.46% to $0.38, with a market cap of $16.9 million.
Senti Biosciences' after-market drop may reflect investor concerns, potentially leading to further short-term declines.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Zura Bio's shares decreased by 7.68% to $4.45, with a market cap of $191.7 million.
Zura Bio's stock price drop could continue if the negative market sentiment carries into the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80